In this study we synthesized quaternary ammonium halide–containing cellulose derivatives (PQ-Cl, PQ-Br, PQ-F) for use as defect passivation additives in methylammonium lead iodide (MAPbI3)–based inverted perovskite solar cells (PVSCs). The...
In this study, we positioned three quaternary ammonium halide-containing cellulose derivatives (PQF, PQCl, PQBr) as interfacial modification layers between the nickel oxide (NiOx) and methylammonium lead iodide (MAPbI3) layers of inverted perovskite solar cells (PVSCs). Inserting PQCl between the NiOx and MAPbI3 layers improved the interfacial contact, promoted the crystal growth, and passivated the interface and crystal defects, thereby resulting in MAPbI3 layers having larger crystal grains, better crystal quality, and lower surface roughness. Accordingly, the photovoltaic (PV) properties of PVSCs fabricated with PQCl-modified NiOx layers were improved when compared with those of the pristine sample. Furthermore, the PV properties of the PQCl-based PVSCs were much better than those of their PQF- and PQBr-based counterparts. A PVSC fabricated with PQCl-modified NiOx (fluorine-doped tin oxide/NiOx/PQCl-0.05/MAPbI3/PC61BM/bathocuproine/Ag) exhibited the best PV performance, with a photoconversion efficiency (PCE) of 14.40%, an open-circuit voltage of 1.06 V, a short-circuit current density of 18.35 mA/cm3, and a fill factor of 74.0%. Moreover, the PV parameters of the PVSC incorporating the PQCl-modified NiOx were further enhanced when blending MAPbI3 with PQCl. We obtained a PCE of 16.53% for this MAPbI3:PQCl-based PVSC. This PQCl-based PVSC retained 80% of its initial PCE after 900 h of storage under ambient conditions (30 °C; 60% relative humidity).
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.